Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Lib Dems to vote on HIV blocking drug

'Pre-exposure prophylaxis' can prevent HIV before it's too late, and the Liberal Democrats want it available on the NHS

Tom Peck
Friday 16 September 2016 12:36 EDT
Comments
Pre-exposure prophylaxis drug Truvada
Pre-exposure prophylaxis drug Truvada (Getty Images (Justin Sullivan))

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

The Liberal Democrats will call for drugs that block the contraction of HIV to be made available on the NHS.

Advancements in ‘pre-exposure prophylaxis’ (PrEP)mean that individuals at risk of contracting HIV - principally gay men - can now take drugs that block the virus. Studies suggest that in the long term this not only prevents the spread of the disease but is also more cost-effective than retroviral treatment.

At the party’s Autumn Conference, which begins on Saturday, Liberal Democrat delegates will vote on a motion to call for the fast tracking of pre-exposure prophylaxis to be made available on the NHS for the most at-risk people.

In August a high court ruling in a case brought by the National Aids Trust concluded there was 'no legal barrier' preventing the NHS from making PrEP available for free.

There are currently over 100,000 people living with HIV in the UK. In 2014 there were 6,151 new HIV diagnoses.

Currently the preventative drug, Truvada, is only available privately, and costs £400 a month. Research by Public Health England estimated that the widespread availability of Truvada could prevent more than 7,000 infections annually by 2020.

In March of this year, NHS England said it would not provide acess to pre-exposure prophylaxis, and said that that HIV prevention services are the responsibility of local authorities.

But it did announce a two year study of its impact, with testing on 500 men.

A 2014 study by the Medical Research Council found Truvada was 86 per cent effective in preventing the contraction of HIV.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in